Become part of our journey
Tzu offers clinical evaluation information for pharma partners
01
Improving early drug
evaluation
Tzu measures target expression and resistance mechanisms in clinical evaluation.
Tzu database can be used for in silico extrapolation to expanded patient cohorts and indications.
02
Target identification and validation in pre-treated metastatic disease
Tzu provides target expression data in pre-treated, actively metastasizing disease.
Tzu database allows for the identification of more relevant targets.
03
Patient stratification
Tzu CTC target expression analysis can identify target expression correlation with overall response rates.
Stratification based on CTC target expression could improve overall response rates in pre-selected cohorts.
